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Review Article
Grown up Congenital Heart Disease patient presenting for
non cardiac surgery: Anaesthetic implications
Mohammad Hamid, Mansoor Ahmed Khan, Mohammad Irfan Akhtar, Hameedullah, Saleemullah,
Khalid Samad, Fazal Hameed Khan
Department of Anaesthesia, Aga Khan University Hospital, Karachi.
Abstract
Congenital heart disease patients surviving to
adulthood have increased over the years due to various reasons.
These patients are admitted in the hospital for non cardiac
surgeries and other procedures more often than normal adult
population. Management of grown up congenital heart disease
patient presents a challenge during perioperative period for
cardiologists, surgeons, intensivists and particularly for the
anaesthetist. Management issues include psychological and
physiological impact on the patient, complexity of defects,
presence of previous palliative procedure, impact of
anaesthetic agents on shunting and myocardium, endocarditis
prophylaxis and associated extra cardiac anamolies.
Introduction
Population of adults with congenital heart disease
(CHD) has increased over the years1 due to improvement in
paediatric cardiology, improved surgical and anaesthetic
techniques2 and better postoperative care. Expectations are that
soon there will be more adults than children with CHD who
have undergone some sort of palliative or corrective surgery.3
Incidence of CHD is about 0.8% of all live births4 and 85% of
these CHD patients are expected to survive to adulthood in
USA.5 Early surgical intervention has also improved their
chances of survival6 and reduces complications associated with
heart defects.
Presence of grown up congenital heart (GUCH) disease
poses increased risk of mortality and morbidity under
anaesthesia.7 Anaesthetic management of these patients
particularly the uncorrected group, in the operating room is
challenging in several respects. Firstly, some heart defects are
so complex that involvement of paediatric cardiologists and
intensivists is necessary for complete understanding of the
anatomy and pathophysiology. Additionally the management is
quite complex and the anaesthetist needs to make an
individualized anaesthetic plan8 after several considerations.
These essentially look at the effect of anaesthetic drugs on the
heart and shunt, fluid management, effect of ventilatory
changes on shunts and how to avoid pulmonary hypertension.
Most of these CHD defects can be categorized into
those associated with increased pulmonary flow, reduced
pulmonary flow and obstructive lesions. Other factors which
should be considered are age of the patient, cardiac lesion,
previous surgery performed (palliative or corrective), presence
of cardiac complication and associated congenital anomalies.
Preoperative Considerations:
GUCH patients coming to preoperative clinic can be
grouped into three categories: Non operated patient; patient
with previous palliative surgery9 and patient with previous
corrective surgery. Patients with total corrective surgery
may still have residual defects. These patients may have
single ventricle physiology, single RV or complex intra
cardiac baffles.
Detailed information should be obtained about cardiac
lesion, altered physiology and its implications under
anaesthesia. Information about the age is very important as
some lesions require early repair. Delayed surgery may
otherwise lead to complications like pulmonary HTN, poor
development of pulmonary vessels and failure to gain weight,
which indicate cardio respiratory decompensation. Poor
exercise tolerance is indicated by fatigue and dyspnoea on
feeding, irritability and failure to gain weight. Previous cardiac
and non cardiac surgeries and prolonged intubation should be
enquired as they suggest subglottic stenosis.
Cyanosis and congestive heart failure (CHF) are major
manifestations of CHD. Cyanosis occurs due to decreased
pulmonary flow anatomically or functionally (Mixing lesion).
Cyanosis may be permanent or appears intermittently. Central
cyanosis is recognizable when deoxygenated haemoglobin in
arterial blood is > 3 gm/dl.
Along with left ventricular function, the right
ventricular function should also be assessed as it is equally
important in the paediatric CHD patient. Patients with high
pulmonary flow may present with tachycardia, tachypnoea,
irritability, cardiomegaly and hepatomegaly. History of
wheezing, frequent respiratory infection and pneumonia is also
common. The amount of cardiac reserve is assessed by
exercise tolerance in older children. Pregnant patients with
GUCH require special attention on preoperative evaluation.
These patients need regular follow up, early involvement of
anaesthetist, assessment of degree of cardiovascular
impairment and optimization of pulmonary vascular resistance.
High foetal mortality10 is seen in mothers particularly with low
saturation and very high haematocrit levels. 
Associated non cardiac congenital anomalies include
musculoskeletal abnormalities 8.8%, neurologic defects 6.9%
and genito urinary irregularities 5.3%. Downs syndrome
patients may have atlanto -occipital subluxation.
Drug history can show the use of warfarin,
antidepressants, diuretics and anti arrhythmics with their
associated side effects. Laboratory investigation should be
tailored accordingly.
NPO orders should be clearly written with timing if
possible. Dehydration should be avoided in cyanotic GUCH
patients. If timing of surgery is uncertain then an IV line should
be placed and fluids started.
Midazolam11 is the preferred sedative to reduce oxygen
consumption in the doses of 0.5 mg/kg orally half hour before
surgery. If IV is present then incremental doses of 0.1 - 0.25 mg
midazolam can be given.
Endocarditis prophylaxis has recently been revised12,13
For dental procedures AHA recommend prophylaxis in
patients is a follows:
 When gingival tissues manipulated, or periapical region of
teeth or perforation of oral mucosa 
 Prior history of infective endocarditis
 Non-repaired cyanotic congenital heart disease (CHD),
including shunts and conduits
 Complete CHD repair within the previous six months
 Repaired CHD with residual defects
Antibiotic for infective endocarditis prophylaxis is no longer
indicated in patients with 
 Aortic stenosis, mitral stenosis, or symptomatic or
asymptomatic mitral valve prolapse.
 Genitourinary and gastrointestinal tract
procedures (transesophageal echocardiography,
esophagogastroduodenoscopy, colonoscopy, etc.) do
not warrant infective endocarditis prophylaxis
unless active infection is present.
Investigation:
Complete blood count and coagulation profile should
always be checked. Polycythaemia14 increases blood viscosity
which leads to thrombosis and infarction in cerebral, renal and
pulmonary region. PT and PTT are usually abnormal in the
polycythaemic patient. Coagulation abnormalities also occur
due to platelet dysfunction, hypofibrinogenaemia and factor
deficiencies. Preoperative phlebotomy15 is performed in
symptomatic hyperviscosity and HCT > 65%. Dehydration
may further aggravate symptoms and should be corrected
before deciding about phlebotomy. WBC count and CRP gives
clue to the diagnosis of infection.
Serum electrolytes should be checked in patients
receiving diuretics. Hypocalcaemia is commonly found in
patients with Di George syndrome. Recent ECG, ECHO and
catheterization findings are very important to decide about
anaesthesia management. ECG may show ventricular strain or
hypertrophy. ECHO used for doppler and colour flow mapping
while catheterization is used for information about pressures in
different chambers, magnitude of shunt and coronary anatomy. 
The chest X-Ray shows the heart position
(Dextrocardia) and size, atelectasis, acute respiratory infection,
vascular markings and elevated hemidiaphragm. Patients with
diminished pulmonary blood flow show reduced pulmonary
markings.
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Intraoperative Considerations:
All intravenous tubings, free of air bubble and
preferably filters,16 should be placed in patients with
Eisenmenger's syndrome. Hypothermia should be avoided and.
Polycythaemic patient must be well hydrated17 before
induction either by IV or orally. All commonly used induction
agents are well tolerated depending on the rate and dose of the
drug. Reduction in SVR should be considered when using
intravenous agents. Inhalation induction is acceptable in
GUCH patients with simple cardiac lesion. Patients with poor
cardiac function, who requires ionotropes preoperatively, may
not tolerate inhalation induction. Ionotropes should be
continued and IV induction agents titrated. Decision about
invasive monitoring should be individualized according to the
type of surgery and cardiac lesion. Internal juglar vein
cannulation may pose a risk of thromboembolism in patients
with Fontan circulation. In addition pulmonary artery catheter
placement may be difficult in patients with anatomical
abnormalities and may be misleading in patients with intra
cardiac shunt. Use of ECHO and blood gases may provide
useful information instead of pulmonary artery catheter. 
Intraoperative Management:
Depends on presence of shunt, pulmonary HTN,
hypoxaemia. Ventricular dysfunction, pulmonary flow and
arrhythmia.
Shunt:
These are abnormal communications (congenital or
surgically created) between heart chambers or blood vessels.
Blood flow through shunt depends upon diameter of defect and
balance between systemic and vascular resistance. Balance
between SVR and PVR is essential in the anaesthetic
management of patient with shunts. 
Left to Right Shunt (ASD, VSD, PDA, AV canal
defects, PAVD, BT shunt):
It has minimal effect on inhalation or intravenous
induction and decreases with the drop in SVR or an increase in
PVR. Left to right shunts leads to excess pulmonary blood
flow. Patients are acyanotic but deterioration in gas exchange
may result from pulmonary congestion. 1-1.5 MAC of
Isoflurane, halothane and sevoflurane has no effect on Qp: Qs
ratio in patients with isolated ASD or VSD during mechanical
ventilation.18 Remember High PaO2 and low PaCO2 have
pulmonary vasodilating properties which in turn may further
increase pulmonary congestion. 100% oxygen and
hyperventilation in patients with L-R shunt should be avoided.
Patients with PDA are more vulnerable to coronary
ischaemia19 due to ongoing pulmonary runoff during the
diastolic phase of the cardiac cycle and potential for low
diastolic blood pressure. Therefore DBP should be monitored
during surgery. Modified Blalock Taussig shunt (BT shunt) is
an artificial shunt between subclavian artery (usually right) and
pulmonary artery. Its dimension is fixed so its output is
proportional to SVR and in case of systemic hypotension, the
pulmonary blood flow will be reduced. Blood pressure in the
arm will be low due to BT shunt, so pressure monitoring in the
ipsilateral arm should be avoided.
Right to Left:
Intra cardiac shunts prolong inhalation induction
while IV induction is faster. R-L shunt (e.g. TOF) or shunt
reversal occur when SVR drops or PVR increases.20 Increase
R-L shunting leads to drop in SaO2 which will not respond to
increasing inspired oxygen concentration. Dead space
ventilation will be increased due to reduced pulmonary flow.
Hypercyanotic spell under anaesthesia responds to volume,
Increase SVR with alpha agonists such as Phenylephrine and
decreasing right ventricular outflow track obstruction with
beta blockade.
Hypoxaemia:
Uncorrected or partially palliated GUCH patients may
present with hypoxaemia. Two mechanisms are basically
responsible for hypoxaemia: Inadequate pulmonary blood
flow and/or admixture of deoxygenated with oxygenated
blood in systemic circulation. These patients are
polycythaemic with its associated complications. Dehydration
should be avoided at all costs.
The anaesthetic management during induction and
maintenance in patients with limited pulmonary blood flow
includes adequate hydration, maintenance of systemic blood
pressure, minimizing additional resistance to pulmonary blood
flow and avoid sudden increase in oxygen demand (crying,
struggling, and inadequate level of anaesthesia).
Those patients in whom pulmonary flow is normal and
hypoxaemia is due to mixing of pulmonary and systemic
blood, the management is more complicated. Pulmonary
vasodilation in these patients increases cardiac work and
decreases systemic blood pressure. Normal SaO2 in these
patients should not be expected and myocardial contractility
and balance between systemic and pulmonary flow should be
maintained.
Pulmonary Hypertension:
Mean pulmonary artery pressure greater than 25 mm
Hg at rest is defined as Pulmonary hypertension (PHTN). High
pulmonary flow as occurs in unrestricted L-R shunt will lead to
CHF and pulmonary HTN. Initially pulmonary HTN is
reactive and responds to hypothermia, stress, pain, acidosis,
hypercarbia, hypoxia and elevated intrathoracic pressure but
later pulmonary HTN becomes fixed. This last stage, where
957 J Pak Med Assoc
pulmonary vascular resistance (PVR) exceeds SVR and
symptoms appear due to R   L shunt, is the Eisenmenger
syndrome.13
Eisenmenger Syndrome:
This is the commonest reason for cyanosis in GUCH
patients. These patients have very high PVR (> 800 dynes cm-
5)21 and reversal or bidirectional intracardiac shunt. Most of
these adults have simple congenital cardiac lesion which has
progressed to severe pulmonary HTN while patients with
complex lesions usually manifest with this syndrome early in
life. Eisemenger patients usually have hypoxaemia, myocardial
dysfunction and arrhythmias. 
Anaesthetic risk is quite high even for minor surgeries22
including cardiac arrest and pulmonary hypertensive crisis.23 In
addition, these patients are high risk for bleeding due to platelet
dysfunction, thrombosis due to Polycythaemia, paradoxical
embolism and arrhythmia. Preoperative phlebotomy is
indicated in patients with hyperviscosity syndrome.
Intravenous fluid should be administered in preoperative
fasting phase to avoid hypotension episodes. Anaesthetic
management focused on preventing further increase in R-L
shunt by keeping SVR high and PVR low, maintaining
myocardial contractility and prevention of arrhythmia and
hypovolumia. General anaesthesia is preferred by most
anaesthetists due to fear of reduced SVR by regional
anaesthesia. Regional anaesthesia can be used24,25 but SVR
should be maintained at all cost. Watch for ventricular and
supraventricular tachycardia in the postoperative phase and
keep them in ICU or high dependency unit.26 Pregnancy carries
a very high risk of mortality and should be avoided.
Ventricular Dysfunction and Arrhythmias:
Impaired ventricular function20 occurs due to volume
overload (Large shunts, valvular regurgitation), Obstructive
conditions and cardiac muscle diseases. Patient may present
with tachycardia, tachypnoea, pulmonary congestion,
hepatomegaly, gallop rhythm, hypotension, and decrease
capillary refill. Arterial blood gas and X-Ray may show
metabolic acidosis and pulmonary oedema respectively.
Elective surgery should be postponed in patients with
signs and symptoms of cardiac failure for optimization. Patient
may require digoxin, diuretics and ionotropes. Mechanical
ventilation may be necessary for pulmonary oedema.
Etomidate and fentanyl provide cardiovascular stability at the
time of induction. Intravenous drugs take longer time to reach
target areas due to prolonged circulatory time in patients with
cardiac failure. Limit the use of inhalation anaesthetics due to
associated myocardial depression. Maintain normal sinus
rhythm and preload during anaesthesia. After load reduction by
vasodilators may be required in many situations to reduce
cardiac workload and improve cardiac output.
Arrhythmias are very common in GUCH due to
scarring induced by previous cardiac surgery. In addition to that
over distension of atria or ventricular can also lead to
arrhythmia.27 Supraventricular arrhythmias are more common
than ventricular and may not respond to medical management.
Anaesthetist has to deal with these patients when they come for
radiofrequency ablation or surgical intervention. TOF related
ventricular tachycardia is more manageable with
antiarrhythmics.
Pregnancy:
Physiological changes during pregnancy pose great
danger to the life of CHD patients.28 These changes include 40
- 50% increase in blood volume, decrease in systemic and
pulmonary vascular resistance and an increase in cardiac
output. In addition, all cardiac chambers dimension increases
particularly the right sided chambers.29 This enormous volume
loading on the heart can easily lead to cardiac failure
(Incidence 4.8%)10 and arrhythmias. Most common
arrhythmias are supraventricular tachyarrhythmias (4.5%)10
particularly in complex CHD. Four predictors of cardiac event
during pregnancy30 are mentioned (1) Prior cardiac event or
arrhythmia (2) Baseline NYHA class >II or cyanosis (3) Left
sided heart obstruction (4) Decreased systemic ventricular
function. 
Multidisciplinary team of an obstetrician, cardiologist,
anaesthesiologist and neonatologist is mandatory to take care
of these patients. Counseling should be started at an early age
by paediatrician as unplanned pregnancy can be life
threatening for patients with CHD. Once pregnancy is
established then regular follow ups and team approach can save
the patient's life. Termination of pregnancy should be
considered when patient is in cardiac failure. Obstetrical
complications include hypertension, thromboembolism and
heart failure. Previously C-Sections under general anaesthesia
was considered to be the best option. But now the use of
epidural catheter with low dose of slow titrated local
anaesthetics is more common for labour and delivery. Risk of
reduction in SVR can be avoided by the use of intrathecal or
epidural narcotics.
Invasive monitoring should be done according to the
type of defect and functional status of patient. Arterial line
should be placed below the obstruction in patients with
coarctation to assess placental flow. An inline air filter can be
used in patients with right to left shunts. Trendlenberg and
lithotomy position31 in Glenn shunt, Fontan and other
cavopulmonary shunts leads to increased central venous
pressure and compromises cerebral perfusion.
Oxytocin should be given at lowest effective dose and
in infusion form. Increased uterine contraction due to oxytocin
can easily lead to heart failure as each contraction pushes 300-
500 ml blood into circulation. Warfarin crosses the placenta16
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and has teratogenic effect while heparin is quite safe and most
of these patients will be on low molecular weight heparin
(LMWH). Most thromboembolic deaths occur during
postpartum period for which LMWH need to be continued. 
Postoperative Care:
High risk patients should be observed either in the
intensive care unit or a monitored bed.17 Arrhythmias and
cardiac ischaemia in the postoperative phase should be
observed. Adequate analgesia should be provided to the
patients to prevent haemodynamic instability. Fluid balance is
very important in these patients. Too much fluid can lead to
cardiac failure in poor ventricular function while too little fluid
causes hypotension.
Spontaneous ventilation is preferred and should be
resumed as soon as possible in the postoperative period. Every
effort should be made to reduce pulmonary pressure in
ventilated patients by avoiding atelectasis, acidosis and by
reducing the duration of inspiration.
Abbreviations: Key
CHD: Congenital Heart Disease. GUCH: Grown up
Congenital Heart Disease. Qp-Qs: Pulmonary to Systemic
Blood Flow Ratio. PaO2: Partial Pressure of Oxygen in Blood.
PaCo2: Partial Pressure of Carbondioxide in Blood. MAC:
Minimal Alveolar Concentration. ToF: Tetralogy of Fallot.
ASD: Atrial Septal Defect. VSD: Ventricular Septal Defect.
PDA: Patent Ductus Arteriosus.
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